Thrombocytopenia is common in adult patients undergoing extracorporeal membrane oxygenation, with a pooled prevalence of 21%, and is accompanied by significant platelet dysfunction regardless of ECMO mode.
Systematic Review (n=7,190)
What is the prevalence of thrombocytopenia and platelet dysfunction in adult patients undergoing ECMO?
Thrombocytopenia and platelet dysfunction are common in adult ECMO patients, occurring in approximately 21% of cases regardless of ECMO mode, highlighting the need for improved monitoring and management strategies.
Effect estimate: 21% prevalence (95% CI 12.9-29.0)
Despite increasing improvement in extracorporeal membrane oxygenation (ECMO) technology and knowledge, thrombocytopenia and impaired platelet function are usual findings in ECMO patients and the underlying mechanisms are only partially elucidated. The purpose of this meta-analysis and systematic review was to thoroughly summarize and discuss the existing knowledge of platelet profile in adult ECMO population. All studies meeting the inclusion criteria (detailed data about platelet count and function) were selected, after screening literature from July 1975 to August 2019. Twenty-one studies from 1.742 abstracts were selected. The pooled prevalence of thrombocytopenia in ECMO patients was 21% (95% CI 12.9-29.0; 14 studies). Thrombocytopenia prevalence was 25.4% (95% CI 10.6-61.4; 4 studies) in veno-venous ECMO, whereas it was 23.2% (95% CI 11.8-34.5; 6 studies) in veno-arterial ECMO. Heparin-induced thrombocytopenia prevalence was 3.7% (95% CI 1.8-5.5; 12 studies). Meta-regression revealed no significant association between ECMO duration and thrombocytopenia. Platelet function impairment was described in 7 studies. Impaired aggregation was shown in 5 studies, whereas loss of platelet receptors was found in one trial, and platelet activation was described in 2 studies. Platelet transfusions were needed in up to 50% of the patients. Red blood cell transfusions were administered from 46 to 100% of the ECMO patients. Bleeding events varied from 16.6 to 50.7%, although the cause and type of haemorrhage was not consistently reported. Thrombocytopenia and platelet dysfunction are common in ECMO patients, regardless the type of ECMO mode. The underlying mechanisms are multifactorial, and understanding and management are still limited. Further research to design appropriate strategies and protocols for its monitoring, management, or prevention should be matter of thorough investigations.
Jiritano et al. (2020) conducted a systematic review in Extracorporeal membrane oxygenation (ECMO) requirement (n=7,190). Extracorporeal membrane oxygenation (ECMO) was evaluated on Occurrence of thrombocytopenia (21% prevalence, 95% CI 12.9-29.0). Thrombocytopenia is common in adult patients undergoing extracorporeal membrane oxygenation, with a pooled prevalence of 21%, and is accompanied by significant platelet dysfunction regardless of ECMO mode.